Raymond James Financial Inc. purchased a new stake in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 85,684 shares of the company’s stock, valued at approximately $3,250,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Wolverine Asset Management LLC lifted its stake in BlackRock Health Sciences Trust by 29.1% during the fourth quarter. Wolverine Asset Management LLC now owns 110,493 shares of the company’s stock valued at $4,191,000 after buying an additional 24,928 shares in the last quarter. Janney Montgomery Scott LLC boosted its position in BlackRock Health Sciences Trust by 40.5% during the fourth quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock valued at $1,244,000 after purchasing an additional 9,455 shares during the last quarter. AlphaStar Capital Management LLC acquired a new position in BlackRock Health Sciences Trust in the fourth quarter worth approximately $878,000. Finally, Hara Capital LLC bought a new stake in BlackRock Health Sciences Trust in the fourth quarter worth $832,000.
BlackRock Health Sciences Trust Stock Performance
Shares of BlackRock Health Sciences Trust stock opened at $38.69 on Friday. The firm has a fifty day simple moving average of $39.89 and a 200-day simple moving average of $40.03. BlackRock Health Sciences Trust has a 1-year low of $36.87 and a 1-year high of $42.64.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
See Also
- Five stocks we like better than BlackRock Health Sciences Trust
- Profitably Trade Stocks at 52-Week Highs
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Stock Splits, Do They Really Impact Investors?
- Top 3 Beverage Stocks Pouring Out Profits
- 3 Ways To Invest In Coffee, Other Than Drinking It
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.